Remove Drug Delivery Remove Insulin Remove Production
article thumbnail

Novo Nordisk once-weekly insulin clears first phase 3 test

pharmaphorum

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. In absolute terms, there were 0.73

Insulin 98
article thumbnail

Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market

XTalks

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In the News: September Regulatory and Development Updates

Camargo

Multiple guidance documents have been released in the last several years outlining the FDA’s current thinking on specific digital health products, such as software as a medical device (SaMD) and mobile medical applications. ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD).

article thumbnail

New Amazon Pharmacy TV Commercials Emphasize Hassle-Free Drug Delivery

XTalks

Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drug delivery service for consumers. In 2023, it introduced RxPass , a prescription drug program that offers common drugs for a flat fee of $5. According to Statista , the global online pharmacy market is predicted to hit $82.42

article thumbnail

Injectable Drug Delivery 2022

pharmaphorum

As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases.

article thumbnail

Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron

XTalks

The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Related: Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market.

Insulin 64
article thumbnail

Medtronic’s MiniMed Insulin Pumps Get Class I FDA Recall

XTalks

The US Food and Drug Administration (FDA) has issued a Class I label for the recall of Medtronic’s MiniMed insulin pumps. The devices are used to regulate blood glucose levels by delivering precise amounts of insulin based on readings from an integrated continuous glucose monitor (CGM).

Insulin 52